Is the headache over for migraine sufferers?
admin The National Institute for Health and Care Excellence (NICE) has endorsed atogepant, a novel oral medication, as a…
Medicine
Hope for Fragile X Syndrome: Zatolmilast granted Orphan Status
This was announced yesterday (April 12) by the executive officer, Isao Teshirogi, of Shionogi BV, the European subsidiary…
Experts hail Cystic Fibrosis drug for babies and children a breakthrough
This discovery marks a significant moment for Cystic Fibrosis treatment, with experts hailing it as a breakthrough. Lead…
Recent pharma industry appointments that should be on your radar
By Isabel Cameron and Liza Laws 11-Apr-2024 – Last updated on 11-Apr-2024 at 12:27 GMT Facebook Twitter Linkedin…
FDA’s thumbs up for Prenosis’ AI for sepsis: a game-changer?
Prenosis, a player in the realm of health technology, has secured this milestone with the full authorization of…
Elisa Cascade on why women should never be afraid to ask
OSP: Could you give us an overview of your work? With more than 30 years of experience in…
Andaman7 unveils AI-powered health record update
This update introduces three new AI tools geared towards providing patients with deeper insights into their health records,…
Can NHS England and Gilead Sciences eradicate hep C by 2025?
This partnership aims to eliminate hepatitis C by 2025, aligning with global efforts to eradicate the virus and…
Step forward in Scotland for endometrial cancer treatment
Clinicians in Scotland can now administer dostarlimab in conjunction with platinum-containing chemotherapy for adult patients diagnosed with mismatch…
Medicxi invests $40m in D3 Bio, enhancing oncology pipeline
The investment will accelerate the development of D3 Bio’s pipeline of oncology compounds, particularly its lead asset DS3-001.…
FDA approves J&J’s OPSYNVI for pulmonary arterial hypertension patients
It is the first and only once-daily single-tablet combination therapy by the US Food and Drug Administration (FDA).…
Beacon Biosignals expands sleep analysis capabilities
This milestone marks a significant expansion of Beacon’s analysis platform, extending its application from at-home sleep monitoring to…
How can the industry overcome real-world data integration challenges?
Q: How has the use of data evolved in clinical trials and what are the challenges that the…
Dr Laura Trotta – ‘I joined CluePoints because of the research but also the mindset’
We sat down with Dr Laura to find out the origins of her fascination with science, the importance…
More from Pluss as it launches Celsure XL VIP pallets
The company is aiming to transform pharmaceutical shipping and storage standards worldwide. Engineered to meet the evolving needs…
Trialbee -on a mission of improving patient recruitment
During the successful SCOPE Summit held in Orlando earlier this year, OSP was delighted to catch up with…
More from Pluss as it launches Celsure XL VIP pallets
The company is aiming to transform pharmaceutical shipping and storage standards worldwide. Engineered to meet the evolving needs…
Vox Pop Pharma – the industry speaks
The news that broke yesterday (April 3) confirmed the collaboration’s aim to speed up the creation of safer…
Using AI – SimBioSys and General Inception’s cancer pact
The collaboration, announced today (April 3), is poised to leverage advanced AI and biophysical modeling to gain deeper…
Molecure’s 2023 milestones and what lies ahead
The company wantd to share some of its highlights and significant advancements in both clinical and preclinical programs.…
HUTCHMED & Innovent Secure NDA for cancer combo in China
The drug is intended for the treatment of advanced endometrial cancer and the news carries significant weight as…
Bora Pharmaceuticals acquires Upsher-Smith from Sawai and Sumitomo
With this acquisition, Upsher-Smith now operates as a wholly-owned subsidiary under the Bora Group umbrella. Bobby Sheng, chairman…
Quibim AI: Revolutionizing liver disease diagnosis
The device is aimed at transforming the diagnosis and management of diffuse liver diseases through advanced AI-driven MRI…
Enhancing AI in the clinical trial landscape
OSP: Could you start by sharing a bit about your background and how you got involved with Cluepoints?…
Denmark and NVIDIA aiding innovation across multiple sectors
At the heart of this initiative lies the deployment of one of the world’s most powerful AI supercomputers,…
Partnership announced to advance personalised medicine
This is intending to advance the development of personalised medicines, improve drug efficacy and outcomes in patients with…
This week’s woman in science
From math hater to a leader in clinical data, it’s been a long journey for Jennifer Visser-Rogers, vice…
The trial has started – can psychedelics help with alcohol addiction?
The trial, already underway at King’s College London, will now expand to include Clerkenwell Health’s research facility near…
integrating technology to enhance the patient experience
It was an insightful and interesting discussion about feeling close to patients as well as the importance of…
skip the cliches and focus on the customers
In April 2022, Anju, a leading provider of comprehensive software solutions to the life sciences industry, announced the…
Beacon Biosignals expands sleep analysis capabilities
This milestone marks a significant expansion of Beacon’s analysis platform, extending its application from at-home sleep monitoring to…
using real-world data to bridge the evidence gap
LL: Before we delve into the specifics of your work at Atropos Health, could you provide a bit…
how is ICON overcoming real-world challenges?
In an interview he spoke to OSP about data integration and overcoming challenges to optimise clinical trial diversity.…
Meyos €2.3 million for improving lives of CKD patients
Led by Cenitz and joined by investors including KIMA Ventures, Advans Lab, and Bpifrance, the funding will support…
can it transfrom clinical research?
By integrating various patient-centric outcomes into a single treatment assessment, One2Treat aims to accelerate the delivery of new…
Safeguarding emotional well-being through rare disease journeys
The Foundation is a patient-led nonprofit organization dedicated to enhancing access to diagnosis, research, and care for individuals…
FDA approves J&J’s OPSYNVI for pulmonary arterial hypertension patients
It is the first and only once-daily single-tablet combination therapy by the US Food and Drug Administration (FDA).…
eClinical empowering organizations to be more efficient and effective
During SCOPE 2024 in Orlando, Dawn Kaminski, vice president of business development operations at eClinical Solutions, shared valuable…
DP World building resilience into healthcare supply chains
This is the company’s approach despite being amidst increasing disruptions to global trade. With 1,000 jobs already created…
myTomorrows collaborates with the ALS Association
myTomorrows is a global health technology company and says it is revolutionizing the landscape of clinical trial accessibility…
What are pharma titans hoping to achieve at this year’s DCAT?
Outsourcing Pharma addressed a number of those attending to produce a ‘written roundtable of what these companies wanted…
‘British companies investing in the UK should not be headline news’
The news comes after AstraZeneca CEO Pascal Soriot previously branded the UK as a ‘very unattractive’ place to…
Quibim AI: Revolutionizing liver disease diagnosis
The device is aimed at transforming the diagnosis and management of diffuse liver diseases through advanced AI-driven MRI…
Merck invests €300M in Korea bioprocessing center
This significant investment marks the largest by Merck’s Life Science business sector in the Asia-Pacific region to date…
Lonza to acquire manufacturing site from Roche in major $1.2 billion deal
The site, in Vacaville, California, is one of the largest biologics manufacturing facilities in the world, with a…
Roquette snaps up IFF Pharma Solutions for $2.85 billion
According to Roquette, the tie-up will ‘rebalance’ its portfolio across health and nutrition, as well as expanding its…
Women in Science – Abzena’s Petra Dieterich on creating new medicines
She has held leadership positions in project management, technical operations, and business development. Working in the CRO and…
Boost for patients with schizophrenia as BSM completes $14BN deal
This acquisition marks a significant milestone in the healthcare industry, particularly in the field of neuroscience, as it…
FDA takes proactive approach to AI with clear strategy
With a dual focus on fostering innovation and ensuring patient safety, the FDA’s approach seeks to provide regulatory…
Developing angina drug shows promise in trial with no patient headaches
The drug is aimed at treating chronic stable angina pectoris and conducted in Portugal, the exploratory phase 1a…
An alternative to Wim Hof’s icy dips? Discover nervous system modulator Nurosym
This approach, along with the increasingly popular practice of cold exposure, is reshaping the pharma and wearable industry’s…
Chronic pain clinical trial produces highly encouraging results
The analysis, conducted by York Health Economic Consulting (YHEC), revealed compelling insights into the efficacy and cost-effectiveness of…
AION Labs’ CombinAble.AI: AI-powered antibody design redefined
This startup, born out of AION Labs’ startup challenge, aims to enhance the development of biological therapeutics by…
Women in Science – Maravai’s Kate Broderick’s fascinating story
Could you give us an overview of your work? I am the chief innovation officer at Maravai Life…
A Conversation with Dave Hanaman
I recently had the privilege of engaging in an enlightening conversation with Dave Hanaman, the co-founder of Curavit.…
eClinical empowering organizations to be more efficient and effective
eClinical Innovations Streamline Clinical Trial Processes: Insights from Dawn Kaminski In the fast-evolving landscape of clinical trials, technological…
AION Labs’ CombinAble.AI: AI-powered antibody design redefined
This startup, born out of AION Labs’ startup challenge, aims to enhance the development of biological therapeutics by…
Urgent need for more epilepsy treatments says Angelini Pharma
Partnering with scale-up Wazoku, Angelini Pharma announced yesterday (March 11) that it aims to make use of the…
Cresset expands North American presence with new Boston site
The company has taken a significant step towards its international expansion by establishing a new facility in Boston,…
Negev Capital celebrates psychedelic medicine milestones across globe
It says three of its companies have recently made groundbreaking achievements including Beckley Psytech, Filament Health, and MindBio…
Insights from Medable’s Colin Weller
The purpose of the discussion was to delve a bit deeper into the challenges and advancements in the…
James Riddlle of Advarra shares insights on clinical trial engagement
James Riddle, the company’s senior vice president of global review services operations, shares valuable insights into the company’s…
Metabolon introduces ‘groundbreaking’ bioinformatics platform
The announcement was made at Biomarkers UK, and it was used as an opportunity to showcase Metabolon’s latest…
Medidata’s data-driven solutions to enhance patient experiences
They discuss their roles and experiences and how Medidata handles clinical research. The conversation covers topics ranging from…
ClinOne launches enhanced self-service platform
This expansion, powered by True Software as a Service (SaaS), introduces advanced self-service configuration management capabilities, empowering users…
Almac Group expands facilities to meet growing client demand
These expansions cater to the rising demand for commercial manufacturing, packaging, and peptide production, bolstering the operations of…
Slope at SCOPE – has the sample management revolution only just begun?
During SCOPE 2024 held in Orlando, he shared insights into the complexities of sample management and data reconciliation,…
Parents inspire dementia-friendly finance app
This investment is poised to propel financial inclusion and equality for those navigating the challenges of dementia. It…
How curiosity and determination inspired Hayley Crowe’s journey from bench to c-suite
BPR: Could you give us an overview of the work that you do at Purolite? What do you…
Form Bio and Gingko Bioworks join to accelerate drug development
This collaboration integrates Ginkgo’s licensable assets and manufacturing capabilities with Form Bio’s cutting-edge AI-driven solutions for gene therapy…
Veterans’ charities rally to help find volunteers for PTSD trial
To find the 40, it will need to screen up to 1,000 people which is why several leading…
Drug discovery key to Cresset and Enamine partnership
The partnership aims to champion innovative solutions for the early stages of the drug discovery process. The companies…
Medidata’s data-driven solutions to enhance patient experiences
They discuss their roles and experiences and how Medidata handles clinical research. The conversation covers topics ranging from…
Survey uncovers several critical factors motivating physicians
They are across diverse therapeutic areas regarding their participation in clinical trials, challenges faced, and the status of…
ICON’s Kathleen Mandziuk drug development journey
She explains how the intense experience now gives her a new sense of pride and dedication to the…
Proscia partners with Pramana to enhance digital pathology solutions
This partnership marks Pramana’s integration into the Proscia Ready partner alliance, aimed at empowering life sciences organizations and…
Emmes submits Duchenne video assessment qualification plan to FDA
The company has officially submitted its Duchenne Video Assessment (DVA) qualification plan to the US Food and Drug…
New innovation hub launched by RSSL
This dedicated platform aims to bolster small- and medium-sized biotech organisations by providing them with essential resources and…
Radboud University – finding the best way to diagnose rare diseases
Deploying genomic technologies helps researchers to better understand the causal mechanisms of diseases improving the accuracy of diagnoses…
First participant dosed in phase 1 clinical trial for RXC008
The company focuses on discovering and developing small-molecule, targeted therapeutics for the treatment of fibrotic disease and cancer.…
Global biotech, Lifebit, achieves significant milestone
The company says this achievement signifies a major advancement in research and development capabilities within the pharmaceutical industry,…
Biogen’s positive step for ALS and neuromuscular disease patients
As a result, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted…
ICON’s Kathleen Mandziuk drug development journey
She explains how the intense experience now gives her a new sense of pride and dedication to the…
Survey uncovers several critical factors motivating physicians
They are across diverse therapeutic areas regarding their participation in clinical trials, challenges faced, and the status of…
join our panel of industry experts
Gone are the days when oral methods were the primary means of administering medication. Today, continuous innovations have…
Genuinely exciting phase 3 results for CymaBay’s seladelpar
CymaBay Therapeutics, Inc., a biopharmaceutical company focusing on innovative therapies for liver and chronic diseases, recently (Feb 21)…
uMotif and MoCA collaborate to deepen commitment to CNS research
This collaboration aims to streamline the process of capturing cognitive function and eCOA/ePRO data, marking a significant milestone…
Artax announces first patient dosed in psoriasis treatment trial
According to the National Instituye of Arthritis and Musculoskeletal and Skin Diseases, psoriasis is a chronic, long-lasting disease…
Rare diseases interview with Clincierge’s CEO, Scott Gray
It was created by The European Organization for Rare Diseases (EURORDIS) to bring together industry stakeholders to advocate…
AstraZeneca’s Tagrisso approved as an important new treatment option
AstraZeneca’s small molecule Tagrisso (osimertinib) with the addition of chemotherapy has been approved in the US for the treatment of…
Clerkenwell Health’s psychedelic drug trial seeks participants
With treatment-resistant depression, standard solutions aren’t enough. They might not make an impact or your symptoms may only…
Doctor at Mendel AI invents a Google for medical records
Going many steps further than just reshaping technology, Dr Karim Galil has been a big part of creating…
From Principal IRB to Univo
It is a next-generation institutional review board (IRB) recently acquired by QHP Capital, an investment manager exclusively focused…
OVID Health’s initiave rewarding companies’ patient-centricity launches
Health communications consultancy, OVID Health made the announcement today (February 22) that the only Patient Partnership Initiative (PPI)…
NICE guidance recommends GSK’s Omjjara as treatment option
It can also be used as a treatment for symptoms in adult myelofibrosis patients with moderate to severe…
Florence Healthcare and Slope join forces to strengthen processes
The companies say uniting will address research site demand for end-to-end solutions to increase efficiencies across all trials.…
Women in Science: Sygnature Discovery’s Jane Kendrew
She is now director of translational oncology, at Sygnature Discovery. OSP interviewed Jane to find out more about…
Arvinas doses first patient with previously undruggable disease
Arvinas Inc. is using its first oral PROTAC, or PROteolysis-TArgeting Chimera, protein degrader in development to treat neurodegenerative…
Innovative Trials partners with Oliver Patch Project for trial retention
Brian Burkhardt began the Oliver Patch Project in 2020 after his son, Oliver, was diagnosed. Children going through…
Cele mai bune suplimente alimentare naturale
suplimente alimentare naturale Cele mai bune suplimente alimentare naturale vă ajută să vă creșteți aportul zilnic de vitamine,…
AstraZeneca’s Tagrisso approved as an important new treatment option
AstraZeneca’s small molecule Tagrisso (osimertinib) with the addition of chemotherapy has been approved in the US for the treatment of…
Phesi celebrates 100 million global patient data milestone
The company, a provider of patient-centric data analytics made the announcement today (February 6), that this unparalleled volume…
How Stella Vnook is ‘infusing innovation’ into cell therapies with Likarda’s technology
Having spearheaded the development of companies focused on CAR-T, CAR-NK, and gene-editing technologies, Vnook encountered challenges with CAR-T…
Artax announces first patient dosed in psoriasis treatment trial
According to the National Instituye of Arthritis and Musculoskeletal and Skin Diseases, psoriasis is a chronic, long-lasting disease…
Advarra’s single sign-on for sites
Some of the biggest subject areas included overburdened clinical sites along with patient retention. To improve clinical research,…
dsm-firmenich announces partnership with Zerion for CBD innovation
The company says patients currently have to self-administer large volumes of cannabidiol (CBD) to achieve a helpful therapeutic…
Pharmacies in crisis need Charac’s digital help
Thanks to an injection of funds from private equity firm, Traditum, funds raised are now around the £4…
New data from Japan shows early resolution of common Covid-19 symptoms
The trial met its primary and key secondary endpoints, making ensitrelvir the first antiviral agent to show both…
Roche pulls plug on camonsertib agreement with Repare Therapeutics
Repare has said that it will take back control its global development and commercialization rights to camonsertib (RP-3500),…
First treatment for Friedreich’s ataxia in Europe granted approval
Omaveloxolone will be the first therapy within the European Union to treat Friedreich’s ataxia (FA) in adults and…
New appointments in the pharma industry so far in 2024
Related tags appointments People on the move Pharma industry Jobs Outsourcing Pharma and BioPharma Reporter breaks down the…
Verisense Health adopts Datavant’s data connectivity platform.
The digital health technology and data company made the announcement last week (February 6) that by using the…
IQVIA: Healthcare data regional compliance complexity requires AI, ML and NLP automation
Always the buzz theme at pharma conferences, the subject of artificial intelligence (AI) continues to crop up more…
Good news for Hong Kong as colorectal cancer treatment approved
The announcement was made today (January 30) that there was marketing approval by the Pharmacy and Poisons Board…
Top minds from pharma, academia and tech to sit on ArisGlobal’s new generative AI council
The Global Council is a small and exclusive top-tier group of AI tech, academia, regulatory agency leaders, and…
use of elC may surpass use of paper consent forms
Medable partnered with Duke University Department of Population Health Sciences Bioethics and stakeholder (BASE) lab for the pilot…
Pfizer and Arvinas’ jointly develop oral treatment for breast cancer
Vepdegestrant is a novel oral PROteolysis Targeting Chimera (PROTAC) ER degrader specifically for estrogen receptor-positive and HER2-negative metastatic…
Pharmacies in crisis need Charac’s digital help
Thanks to an injection of funds from private equity firm, Traditum, funds raised are now around the £4…
New appointments in the pharma industry so far in 2024
Related tags appointments People on the move Pharma industry Jobs Outsourcing Pharma and BioPharma Reporter breaks down the…
Rani Therapeutics announces promising phase 1 results for oral Stelara biosimilar
Ustekinumab is a human IgG1қ monoclonal antibody that binds to the p40 protein subunit used by both the…
Brainomix 360 platform for stroke care endorsed by NICE
Brainomix 360 (formerly known as e-Stroke) helps clinical decision-making in stroke and was among more than a dozen…
Immunic’s CSO – on exploring the fascinating world of viruses
She loves her job and works within a team that believes in the power of diverse perspectives and…
Phesi celebrates 100 million global patient data milestone
The company, a provider of patient-centric data analytics made the announcement today (February 6), that this unparalleled volume…
Kinnov Therapeutics alcohol use disorder (AUD) drug progressing well
Historically, the recommended treatment has focused on abstinence and achieving complete sobriety. However, having observed this method’s lack…
finding cancer trial patients like finding needle in haystack
The company recently announced its Omnichannel Network partnership with Massive Bio, a global leader in AI-enabled patient journey…
Lightship at SCOPE 2024 – and its people first approach to trials
Motivated by a commitment to underserved populations, he joined Lightship to prioritize access, choice, and equity in clinical…
Lokavant’s trial platform – a game-changer in the industry
He says Lokavant’s solution can provide valuable insights to help streamline your trial process and ensure its success.…
AI trend to continue at SCOPE 2024
She has more than 15 years in the life science technology industry significant experience in the investigator grant…
Repare Therapeutics receives $40 million Roche payment
It earned the milestone payment from Roche for developing and commercializing camonsertib (RP-3500 or RG6526), an oral small…
EDETEK platform delivers custom configurable workflows
EDETEK provides clinical technology solutions for the biopharmaceutical, medical devices and CRO companies. The new product forms part…
Evaro secures $1.5 million to transform minor healthcare access
Evaro was founded in 2018 by Thuria Wenbar, an emergency doctor and software developer, and her husband, Oskar…
NeoPhore’s small molecule drugs pipeline gets additional £9.6M
Neophore Limited, a neoantigen immune-oncology company, is generating next-generation, immuno-oncology therapeutics to improve clinical outcomes for cancer patients…
Stevanato bringing advanced biopharmaceutical products to market
The company announced that the two new solutions for efficient small batch pharmaceutical manufacturing – the EZ-fill Kit…
GSK drug for enlarged spleen given UK marketing authorisation by MRHA
The drug is for the treatment of disease-related splenomegaly (enlarged spleen) or symptoms in adult patients with moderate…
Stevanato bringing advanced biopharmaceutical products to market
The company announced that the two new solutions for efficient small batch pharmaceutical manufacturing – the EZ-fill Kit…
Good news for Hong Kong as colorectal cancer treatment approved
The announcement was made today (January 30) that there was marketing approval by the Pharmacy and Poisons Board…
IQVIA: Healthcare data regional compliance complexity requires AI, ML and NLP automation
Always the buzz theme at pharma conferences, the subject of artificial intelligence (AI) continues to crop up more…
Pistoia Alliance flagship project IDMP-O published
The global not-for-profit alliance advocates for ‘greater collaboration in life sciences research and development and now plans to…
Curavit at SCOPE 2024 – on seeing green shoots in the industry
The company uses technologies in digital health, cloud computing, and data science to recruit, engage, and monitor diverse…
SCOPE the place to connect and have meaningful chats
The company provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance…
Medable’s hope – driving down the 12-year drug development lifecycle
The company provides an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients,…
SCOPE 2024 – the top space for collaboration across clinical development
The company’s goal is to help life sciences organizations around the world accelerate clinical development initiatives with expert…
SCOPE 2024 – driving innovation in clinical trials
At the zenith of innovation, OM1 crafts solutions that harness the potential of real-world data and artificial intelligence…
Breye Therapeutics ApS developing oral ophthalmology drugs
Breye Therapeutics ApS announced today (January 25) that the first patient has been dosed in a phase 1b/2a…
Partnership to enhance efficiency of development for cancer medicine
The two companies aim to develop the next wave of imaging-based diagnostics for precision medicine. Merck is a…
AI trend to continue at SCOPE 2024
She has more than 15 years in the life science technology industry significant experience in the investigator grant…
Veeva at SCOPE – primary focus will be driving innovation
We put some questions to him in advance of the summit. What are the current top priorities for…
Colleen Acosta – addressing the unmet needs in women’s health
Could you give us an overview of your work? We have a world class team of leaders in…
Gerresheimer medical device manufacturer $88 milliion expansion in US
The expansion will create more than 200 new jobs adding to the 260 it already supports there. The…
Saama platform users now get instant responses to data queries
The company uses AI and advanced analytics to automate key clinical development processes in a bid to accelerate…
Digital records system gives Priory staff more time to care
The system called Nourish means staff will be released from administrative tasks as the system has enabled the…
Clinical Trial Media launches online portal for studies and trials
The company works with pharmaceutical companies through all stages of clinical research made the announcement earlier this month…
Luka Yancopoulos, CEO of Grapevine, on data management and supply chains
Luka Yancopoulos is CEO of Grapevine and explains the importance, and challenges, of standardizing data from different sources…
SGD Pharma’s goal to become market leader in glass packaging
CEO Olivier Rousseau says that SGD Pharma intends to significantly grow in 2024, with a sustained and consistent…
the importance of federal learning for clinical research
He developed a paper on clinical development to proactively address industry issues earlier this month and OSP put…
SmartLabs’ $48 million funding to accelerate scientific development
The company provides flexible laboratory infrastructure and resourcing solutions and welcomed the participation to the funding round from…
Nitisinone brought to rare disease patients thanks to partnership
The partnership, announced today (January 18) will make NITYR (nitisinone) tablets available for eligible patients in the UK…
GSK’s £200 million investment in the UK and $1.1 billion acquisition
The company formerly known as Glaxosmithkline will put the money towards its sites there until 2025 including constructing…
the need for clearly defined regulatory approval
A tour of a mock home with all the technology in place was certainly eye-opening, so we were…
Investment of €10 million for drug delivery company DelSiTech
The financing was co-led by new investors DRW Venture Capital LLC, headquartered in Chicago, and Tolmar International Ltd.,…
KBI Biopharma and Argonaut Manufacturing Services form strategic alliance
The companies say the arrangement provides the seamless manufacturing by combining KBI’s leading drug development and biologics manufacturing…
Cormica Bradford equipment expansion supporting key client programs
The company says it is known for its ‘unwavering commitment to enhancing patient lives through comprehensive testing services’…
Nutriband Inc. signs fentanyl agreement with Kindeva Drug Delivery
Nutriband Inc., a company that develops transdermal pharmaceutical products has signed a commercial development and clinical supply agreement…
Medable hopes new technology will cut trial build time by half
The company that provides technology for modern clinical trials says early application of the technology in electronic clinical…
Gen Li, president and founder of Phesi on data management
Here’s a summary of our question and answer session. How has the role of data management in clinical…
Picodya’s new technology enables real-time monitoring of human immune status
The company is the creator of the first hybrid in vitro diagnostics (IVD) solution for multiplexed point-of-care testing…
MilliporeSigma and ACD/Labs in collaboration for ChemTwins platform
MilliporeSigma’s first release version of its digital reference material (dRM) ChemisTwin provides scientists in quality control labs with…
Fortrea, Advarra and Veeva form partnership to reduce trial burdens
The partnership aims to deliver an integrated patient- and site-centric solution provoding a smooth and effective clinical trial…
Luka Yancopoulos, CEO of Grapevine, on data management and supply chains
Luka Yancopoulos is CEO of Grapevine and explains the importance, and challenges, of standardizing data from different sources…
WNS on the trials and tribulations of data management
The company says that if business partners are able to harness health date with strong partnerships with the…
Hutchmed’s hope for adults with primary immune thrombocytopenia
The company has announced new drug application (NDA) acceptance in China for its small molecule drug, sovleplenib, and…
Nadège Pelletier from childhood microscope to CSO
OSP: Could you give us an overview of your work? As the CSO, I lead Barinthus Bio’s…
Evotec joins forces with the Crohn’s & Colitis Foundation
The foundation is the leading non-profit organization focused on both research and patient support for inflammatory bowel disease…
New technology could ‘meaningfully impact’ brain trauma
According to the company, its central nervous system (CNS) CAPTON platform improves distribution and proportionate drug activity based…
Newron’s evenamide brings good news for patients with CNS diseases
The company, which focuses on the development of therapies for patients with diseases of the central nervous system…
Thermo Fisher’s hope to improve outcomes for ARDS patients
The PPD clinical research business of Thermo Fisher Scientific Inc., a world leader in serving science, has been…
ACG joins coveted list of WEF’s Global Lighthouse Network
The company that says it is the largest of its kind, is celebrating the inclusion of its capsule…
Thermo Fisher’s hope to improve outcomes for ARDS patients
The PPD clinical research business of Thermo Fisher Scientific Inc., a world leader in serving science, has been…
Ketamine myths dispelled by clinic following Matthew Perry’s death
Mental health treatment center, the Ketamine Clinics Los Angeles (KCLA) said the storm surrounding the recently announced cause…
Bristol Myers Squibb buys Karuna Therapeutics for $14 billion
The board of directors at Karuna, a founded entity of PureTech Health, and Bristol Myers Squibb unanimously approved…
Ketamine myths dispelled by clinic following Matthew Perry’s death
Mental health treatment center, the Ketamine Clinics Los Angeles (KCLA) said the storm surrounding the recently announced cause…
Calliditas IgAN treatment, Tarpeyo, given full FDA approval
IgAN or primary immunoglobulin A neuropathy is an autoimmune disease that occurs when clumps of antibodies are deposited…
HIV pathology data now reaching investigators within hours
Established in 1994 and funded by the National Institutes of Health and National Cancer Institution has opted to…
Mission Therapeutics moves kidney disease drug to phase 2 after FDA approval
Up to 160 adults with increased risk for acute kidney injury (AKI) following cardiac surgery are planned to…
UK approves treatment for hot flushes during the menopause
“Hot flushes and night sweats caused by menopause are common, and can have a significant impact on a…
New appointments in the pharma industry
Related tags People on the move Pharma industry Jobs Pharmaceutical industry BioPharma Reporter and Outsourcing Pharma presents its…
The key pharmaceutical trends from 2023 according to industry leaders
There has been no shortage of excitement over 2023 with a huge number of impactful stories. We have…
Five decentralized clinical trial organizations raising big VC cash
As the Covid-19 pandemic raged, lockdowns and strained healthcare systems forced many clinical trials to be delayed or…
Agno Pharma snaps up Particle Sciences to beef up drug product formulation
The acquisition has added Particle Sciences’ specialized drug product formulation technology to the CDMO’s toolkit in addition to…
‘Motherhood makes me a stronger, more compassionate employee’
We discussed what drew her to the field, her career up to this point, and what she’s excited…
FDA approves Arcutis’ skin foam for seborrheic dermatitis
The US Food and Drug Administration (FDA) has approved a topical foam developed by Arcutis Biotherapeutics and branded…
Anagenex and Nimbus join forces to develop small molecule treatments using AI
According to the deal terms, Anagenex will generate billions of biochemistry data points for each disease target nominated…
FDA approval expands Welireg to patients with renal cell carcinoma
Welireg was originally approved by the FDA in 2021 for a rare genetic condition. The latest approval allows…
Anxiety treated with single dose of psychedelic drug in phase 2b trial
Four weeks after receiving a 100 µg dose of the drug candidate, patients saw a significant reduction in…
Astellas Pharma’s treatment for hot flashes and sweats approved
Astellas Pharma Inc. made the announcement today (December 11) that the EC, on December 7, approved Veozatm (fezolinetant)…
‘Therapies that hold immense promise may never see the light of day’
We caught up with Dr. O’Neal to discuss the telltale signs of trouble in clinical trials that sponsors…
Phathom’s impending heartburn treatement given NDA by FDA
The company that focuses on remedies for gastrointestinal diseases announced on December 7 that the US Food and…
Lindus Health and Thirty Madison’s pilot dermatology study
Treatments for various skin conditions, including atopic dermatitis (eczema), can be sought via the platform through asynchronous evidence-based…
Atropos Health and SEQESTER partner to speed up drug development
Atropos Health translates real-world clinical date into personalized real-world evidence and insights announced its partnership with SEQESTER today…
Pharma-grade cannabis contracts secured by Celadon
The UK-company is based on the development, production and sale of the medicines and agreed two commercial contracts…